Project Grant R21MH140123
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$429K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $422,280 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to identify and study novel intracellular proteins that regulate the nanoscopic architecture of the neurexin-1 and neurexin-3 proteins at synapses. The key goals are to use advanced 3D super-resolution imaging techniques to...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund research to investigate the biophysical mechanisms that regulate axon morphology and function. The $375,835 award, effective September 1, 2024, will support a 5-year study conducted by the University of California, San Diego (UCSD) to determine how lipid composition and cytoskeletal structure influence axon shape, ion channel localization, and...
This Project Grant award of $1,505,818.00 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to investigate the role of the neurexin protein in social adaptation and amygdala plasticity. The primary recipient, Rosalind Franklin University of Medicine & Science, will conduct studies to determine how disruptions in the neurexin 1 gene impact the prefrontal cortex to basolateral amygdala circuit and influence...
The National Institute of Mental Health (NIMH) awarded a $1,111,187 Project Grant (CFDA 93.242 Mental Health Research Grants) to Georgetown University to investigate how a gene called CHD1, which is linked to autism spectrum disorder (ASD), impacts synaptic homeostatic plasticity - the mechanisms that stabilize synaptic function. The 5-year research project, which began in July 2024, will employ a multifaceted approach including genetics, electrophysiology, imaging, transcriptomics, and...
This $237,750 federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at the University of California, Merced to elucidate the role of the BAF chromatin remodeling complex in experience-induced neuronal gene transcription and synapse maturation, with implications for understanding autism spectrum disorders (ASD). The key objectives are to determine if the neuronal BAF (NBAF) complex, and...
The National Institute of Mental Health (NIMH) awarded a $692,043 Project Grant (CFDA 93.242 Mental Health Research Grants) to The Regents of the University of California, San Francisco (UCSF) to investigate the role of presynaptic homeostatic plasticity in mental health disorders, including autism and intellectual disability. The research aims to establish a mechanistic framework linking homeostatic plasticity to the genetic underpinnings of these conditions, with the goal of developing...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is funding research to investigate sex-dependent dysregulation of parvalbumin interneurons as a potential pathway to Autism Spectrum Disorder (ASD). The $251,250 award to the Feinstein Institutes for Medical Research will support a study examining the impact of in utero exposure to anti-CASPR2 antibodies on the development and function of parvalbumin...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,049,254 to Cold Spring Harbor Laboratory to investigate the role of transient neuronal connectivity in the development and progression of Fragile X Syndrome, a leading genetic cause of autism. The research aims to elucidate the mechanisms by which sensory inputs and neuromodulatory signals establish and regulate transient neuronal circuits in...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants provides $911,929.00 to the Scripps Research Institute to conduct a 5-year research project titled "Scalable Functional Analysis of Neuropsychiatric Risk Genes with Spatially Integrated in vivo Perturb-Seq." The research aims to use advanced in vivo genetic screening and whole-brain imaging techniques to map the functions of 72 high-confidence autism...